Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar/Interchangeable Rapid-Acting Insulin Aspart (I004) and NovoLog® After Single-Dose Subcutaneous Administration to Healthy Volunteers

Clinical trial NCT07560150 · COMPLETED

Trial details

NCT number: NCT07560150
Sponsor: Amphastar Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Pharmacokinetics Pharmacodynamics Insulin Aspart

Start date: 2026-04-06
Primary completion: 2026-06-22
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.